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Abstract
Introduction: The aim of the study is to describe the frequency of frailty in people with a new 
diagnosis of mild dementia due to Alzheimer’s disease (AD) and dementia with Lewy bodies 
(DLB). Methods: This is a secondary analysis of the Dementia Study of Western Norway (Dem-
vest). For this study, we analysed a sample of 186 patients, 116 with AD and 70 with DLB. Sub-
jects were included at a time in which mild dementia was diagnosed according to consensus 
criteria after comprehensive standardized assessment. Frailty was evaluated retrospectively 
using a frailty index generated from existing data. The cut-off value used to classify an older 
adult as frail was 0.25. Results: The prevalence of frailty was 25.81% (n = 48). In the DLB group, 
37.14% (n = 26) were classified as frail, compared to 18.97% (n = 22) of those with AD (p < 
0.001). The adjusted multivariate analysis revealed an OR of 2.45 (1.15–5.23) for being frail in 
those with DLB when using AD as the reference group. Conclusion: Frailty was higher than 
expected in both types of dementia. The prevalence of frailty was higher in those with DLB 
compared to AD. This new finding underscores the need for a multi-systems approach in both 
dementias, with a particular focus on DLB. © 2019 The Author(s)
Published by S. Karger AG, Basel
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Introduction
Frailty leads to increased vulnerability toward stressors in older adults and is a known 
predictor for several adverse outcomes in this age group [1]. The most popular criteria used in 
order to operationalize frailty are the so-called frailty phenotype and the Frailty Index (FI) [2–4]. 
Studies suggest that around 9–17% of community-dwelling older adults over the age of 60 are 
frail [5, 6]. However, estimates vary depending on the criteria used for defining said condition [6].
With demographic transition, the number of older adults is increasing, and with it the prev-
alence of chronic conditions. Dementia is considered one of these [7], known for its terminal and 
disabling nature, high costs for healthcare systems, and serious consequences for both patients 
and caregivers [7–9]. This condition has traditionally been considered to be independent from 
purely physical domains. However, there is enough evidence to infer that both frailty and 
dementia are main drivers of disability related to aging, as well as for increased mortality [10, 
11]. Dementia affects several systems and leads to many manifestations beyond cognition. For 
instance, it has been associated with geriatric syndromes [12]. Frailty and dementia are multi-
factorial in origin and share common etiological pathways [12]. Thus, both have been conceptu-
alized as converging conditions resulting from cumulative exposure over time [13].
Previous studies have examined the relationship between frailty and cognitive impairment 
with a special focus on Alzheimer’s disease (AD) [14], but none have studied other highly 
disabling and frequent dementias such as DLB (Dementia with Lewy Bodies). DLB is the 
second most common neurodegenerative dementia and is characterized by a tetrad consisting 
of signs and symptoms beyond cognitive impairment [15]. DLB patients have poor prognosis 
on a variety of key outcomes, including frequency and duration of hospital admissions, the 
need for specialized care, under-diagnosis, institutionalization, geriatric syndromes, auto-
nomic impairment, behavioral disturbances, decreased quality of life, and increased care-
giver burden [16–18].
The aim of this study is to describe the frequency of frailty in subjects with newly diag-
nosed mild DLB and mild AD. Given the lack of knowledge on frailty in DLB, it is important to 
estimate the frequency of said condition in this population, since understanding this associ-
ation has the potential for better management and better outcomes.
Materials and Methods
Setting and Participants
We analyzed data from the Dementia Study of Western Norway (Demvest). This is a 
longitudinal cohort study with annual assessment of patients referred to dementia clinics in 
Hordaland and Rogaland counties [19]. Only baseline data were included in this study. The 
centers were contacted by certified mail prior to the beginning of the study and invited to 
refer all patients with suspected dementia. All dementia diagnostic units in the region 
recruited patients to the study. The same National Insurance Scheme with restricted copay-
ments covered all residents of the region. Thus, it was possible to adequately represent 
dementia in the general population. After the main inclusion period, which took place between 
2005 and 2007, we continued to selectively recruit patients with DLB dementia in order to 
enhance the number of patients in this group.
Exclusion criteria were the absence of dementia, having moderate or severe dementia, 
delirium, previous bipolar or psychotic disorder, terminal illness, or recently diagnosed major 
somatic illness, which might significantly impact on cognition, function, or study participation. 
After screening 657 patients, 234 were included at baseline. The sample included 116 
subjects with AD, 70 with DLB, 12 with Parkinson’s disease, 20 had mixed vascular and AD 
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and 16 participants had other types of dementia (frontotemporal dementia n = 4, vascular 
dementia n = 9, and alcohol-related dementia n = 3) [19]. For the purposes of our study, we 
included subjects living with AD and DLB, yielding a total of 186 participants. The youngest 
subject was 50 years old and the oldest was 92 years of age.
Clinical Assessments
The diagnosis of dementia was made according to DSM-IV criteria. It was further clas-
sified as AD dementia when complying with The National Institute of Neurological and 
Communicative Disorders and Stroke-AD and Related Disorders Association guidelines [20] 
and as DLB according to the revised consensus criteria [21]. Two of the study authors inde-
pendently applied the diagnostic criteria. In cases of disagreement, and in patients fulfilling 
more than one set of operationalized diagnostic criteria, the final ascertainment was made 
through consensus. In addition, based on the same evaluation, the consensus criteria for a 
clinical diagnosis of probable DLB were also applied, and ultimately the proportion fulfilling 
the 2 sets of criteria for DLB were compared [19]. Mild dementia was defined as a Mini-Mental 
Status Examination (MMSE) score [22] of at least 20 or a CDR global score = 1. A pathological 
diagnosis was available for 56 patients in the Demvest cohort, proving diagnostic accuracy 
above 80% for both AD and DLB [19, 23].
Patients were evaluated through structured and detailed assessments; in addition, 
relevant information regarding past medical history was taken from medical records in order 
to obtain complete and detailed information about the medical background and comorbid-
ities for each subject. Routine blood and CSF analyses, as well as brain imaging through 
magnetic resonance imaging were also performed. Dopamine transporter SPECT scans were 
available for most patients with suspected DLB [19].
Classification of Frailty 
Collected information was employed to estimate frailty through the FI, which was blinded 
for clinical diagnosis. Our FI included 35 deficits:
(1) Inability to cook for themselves, (2) Inability to keep personal hygiene (shaving, 
hair combing, and dental hygiene), (3) Inability to go to the bathroom by themselves, 
(4) Inability to use the phone, (5) Inability to go shopping, (6) Inability to manage 
their finances, (7) Inability to take own medicines, (8) Inability to manage financial 
responsibilities (pay taxes), (9) Upper gastrointestinal complaints, (10) Lower gastroin-
testinal complaints, (11) Urinary system deficits, (12) Osteomuscular complaints, 
(13) Renal problems, (14) Low serum albumin, (15) Hypoglycemia, (16) Cardiac diseases 
(Arrhythmias, Myocardial infarction, Congestive heart failure), (17) Hypertension, (18) 
Diabetes Mellitus, (19) COPD, (20) Hypothyroidism, (21) Epilepsy, (22) Stroke or Tran-
sient Ischemic Attack, (23) Gait disturbances, (24) Tremor, (25) Smoking, (26) Glaucoma 
or other ophthalmologic diseases, (27) Delirium, (28) Hearing problems, (29) Aphasia, 
(30) Arthropathies, (31) Agitation or aggression, (32) Depression, (33) Anxiety, (34) 
Apathy, and (35) Falls.
Each item was rated as 0 (if no deficit was present) or 1 (if a real deficit was present), 
deficits from 1 to 13 had intermediate scores such as 0, 0.33, 0.66, and 1 according to severity. 
The score for each item was added and then divided by 35 in order to obtain a global score 
for the index. The cutoff value used to define frailty was established at > 0.25 [4].
Statistical Analysis
Descriptive analyses are presented through frequencies and percentages for categorical 
variables, while SDs and means are used for continuous variables. For bivariate comparative 
analyses, χ2-tests or Student t tests were used as appropriate, depending on the distribution 
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of each variable. Multivariate logistic regression models were fitted in order to obtain an OR 
with 95% CI for the association between frailty and the independent variable (AD or DLB). 
The results were then adjusted for sex, age, and MMSE. The level of statistical significance was 
set at p < 0.05. All data were analyzed using STATA 15.
This study was approved by the regional Ethics Committee (2010/633) and the Norwegian 
authorities for the collection of medical data. All data were handled in accordance with 
national health and data privacy protocols. All participants signed an informed consent form 
before inclusion in the study.
Results
The cohort included 186 patients with mean age 76.10 ± 7.59, 116 with AD and 70 with 
DLB. Demographic and clinical characteristics for frail DLB and AD patients are shown in 
Table 1. Frailty was associated with higher age (79.21 ± 5.40 vs. 75.01 ± 7.95, p value ≤0.001), 
male gender (31.88% vs. women 22.22%, p value = 0.51 and lower MMSE scores (22.93 ± 2.62 
vs. 23.81 ± 2.61, p value = 0.045; Table 1).
The global frequency of frailty was 25.81% (n = 48). In DLB, 37.14% (n = 26) of the 
subjects were frail, compared to 18.97% (n = 22) of those with AD (p = 0.006; Table 1 and 
Fig. 1). The adjusted multivariate analysis revealed an OR of 2.45 (1.15–5.23) for frailty in 
subjects with DLB when taking AD as the reference group. This association was statistically 
significant (p value 0.020; Table 2).
Discussion
We found a high general prevalence of frailty within the sample, with an even greater 
prevalence in those living with DLB. The odds for being frail were more than 2 times higher 
in DLB patients when compared with subjects with AD.
Table 1. Descriptive and bivariate analysis
Non-frail Frail p value Total
n (%) or mean ± SD n (%) or mean ± SD n (100%) or mean ± SD
Age, years 75.01±7.95 79.21±5.40 0.0009 76.10±7.59
≤69 96.55 (28) 3.45 (1) 0.003 29
70–79 75.86 (66) 24.14 (21) 87
≥80 64.18 (43) 35.82 (24) 67
Gender 0.5196
Male 47 (68.12) 22 (31.88) 69
Female 91 (77.78) 26 (22.22) 117
MMSE 23.81±2.61 22.93±2.62 0.0458 23.59±2.63
AD 94 (81.03) 22 (18.97) 0.006 116
DLB 44 (62.86) 26 (37.14) 70
Total 138 (74.19) 48 (25.81%) 186
FI 0.15±0.079 0.21±0.01 <0.001 0.18±0.094
MMSE, Mini-Mental Status Examination; FI, frailty index; AD, Alzheimer’s disease; DLB, dementia with 
lewy bodies.
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The trajectories of frailty and dementia share multiple etiologies, features, and related 
factors. However, in contrast with AD, DLB patients are more prone to be frail due to the 
symptoms of the disease per se. (i.e., executive function impairment, decreased mobility, 
motor and non-motor symptoms, psychiatric and autonomous symptoms) and due to the 
consequences of these manifestations (poor adherence and adverse effects to medications, 
polypharmacy, worsening of comorbidities, need for care, falls, geriatric syndromes, among 
others) [24]. Our research group has previously reported high mortality in DLB, which we can 
now infer, may be associated with the high prevalence of frailty [25].
For the purpose of this study, we used the FI because in this context it reflects the 
biological nature of frailty more than other approaches based mainly on physical variables 
and measurements, which can be biased by the illness itself. Furthermore, dementias in 
general have been long seen as diseases that are limited to the brain, focusing on cognitive 
and mental symptoms. However, and more importantly in DLB, other systemic manifesta-
tions and their consequences are very relevant and are usually under-detected or considered 
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Fig. 1. Distribution of people with 
AD and DLB according to the FI. 
DLB, dementia with Lewy bodies; 
AD, Alzheimer’s disease; FI, frailty 
index.
Table 2. Multivariate analysis
Unadjusted Adjusted
OR (95% CI) p value OR (95% CI) p value
AD Ref. Ref.
DLB 2.52 (1.29–4.94) 0.007 2.45 (1.15–5.23) 0.020
Age, years – 1.11 (1.04–1.18) 0.001
Gender – 0.61 (0.28–1.31) 0.211
MMSE – 0.94 (0.82–1.07) 0.381
Model adjusted by sex, age and score in the MMSE.
AD, Alzheimer’s disease; DLB, dementia with lewy bodies; MMSE, Mini-Mental Status Examination.
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It is also relevant to mention that people living with frailty are more likely to develop 
dementia due to several factors including inflammation and endothelial damage [26–28]. 
Thus, targeting frailty as a potentially modifiable factor in the early trajectory of dementia 
seems imperative. The prevalence of frailty found in our study is similar to previous reports 
on AD [29]. A recent systematic review reported the prevalence of frailty within people with 
AD ranging from 11.1 to 50%, with a pooled prevalence of 31.9% in mild and moderate stages 
[14]. However, the association between cognitive impairment and frailty had only been 
reported in AD.
It is important to highlight that people included in this analysis had been recently diag-
nosed with mild dementia, which leads us to conclude that in many cases the frailty process 
starts much before the onset of dementia, and efforts should be made toward prodromal or 
early detection of both neurodegenerative diseases and frailty.
Our study is at risk for potential recruitment bias because of referrals by primary care 
physicians, which may have led to an increased number of patients with complicated dementia 
or neuropsychiatric symptoms. However, referral centers were invited to refer any patients 
with suspected dementia, and patients were included from psychiatric, neurologic, and geri-
atric clinics. MMSE is language and memory dominant and thus less sensitive to the earliest 
changes in DLB patients, although the sensitivity of MMSE is comparable to other screening 
instruments when approaching moderate dementia levels [30]. In addition, we also used the 
CDR to compare dementia severity, which is independent of the cognitive impairment profile. 
Also, healthy controls were not included for comparison. Strengths of the study include 
careful and rigorous diagnostic procedures, assessment through structured instruments, 
longitudinal design, and high postmortem accuracy in the 56 cases with neuropathological 
diagnosis [19, 23]. To the best of our knowledge, this is the first study of its kind to address 
the association between frailty and DLB.
Conclusion
The prevalence of frailty at the time of diagnosis of dementia is high. Clinicians, particularly 
primary care practitioners, are thus encouraged to identify dementia earlier in its trajectory for 
timely and prompt interventions. Understanding frailty in DLB may guide management and 
improve prognosis. Nonetheless, better tools are required in order to allow early or prodromal 
detection of disease and prevent or stop the fragilization process, particularly in diseases such 
as DLB where frailty has shown to be prevalent and has been unexplored.
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